Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Synuca Therapeutics ApS
APS
Active
CVR 45367282
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
2 ansatte
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Synuca Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
0M
-1M
-1M
0M
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
0M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-256
Staff expenses
-69
EBITDA
-325
Depreciation & amort.
-0
EBIT
-325
Net financials
-21
Profit before tax
-346
Tax
-74
Net profit
-273
Balance sheet
DKK thousands
Item
2025
Total assets
345
Equity
-267
Long-term debt
558
Short-term debt
54
Total debt
612
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-32494400.0%
Denne virksomhed
2025
2025
Soliditetsgrad
-77.6%
Denne virksomhed
38.2%
Markedsmedian
303% under markedet
2025
2025
Egenkapitalforrentning
-27281800.0%
Denne virksomhed
18.4%
Markedsmedian
148270752% under markedet
2025
2025
Nettoresultatgrad (af bruttofortjeneste)
-27281800.0%
Denne virksomhed
2025
2025
Aktivomsætning (af bruttofortjeneste)
-0.74×
Denne virksomhed
2025
2025
Gæld/egenkapital
2.29×
Denne virksomhed
0.62×
Markedsmedian
269% over markedet
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-30 – 2025-12-31
View
PDF
More on Synuca Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
